An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Watch video of our genetics workshop at CCC 2018
How a routine blood test could flag type of cardiomyopathy
New WGS study links rare genetic changes to Tetralogy of Fallot
A precision tool to stop sudden cardiac death in children
Where decoding the genes of children with HF will lead